skip to main content

Clinical significance of androgen secretion disorders in men with a malignancy

Wiechno, Pawel ; Poniatowska, Grazyna ; Michalski, Wojciech ; Kucharz, Jakub ; Sadowska, Malgorzata ; Jonska-Gmyrek, Joanna ; Nietupski, Karol ; Rzymowska, Joanna ; Demkow, Tomasz

Medical Oncology, 2017, Vol.34(7), pp.1-9 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
  • Título:
    Clinical significance of androgen secretion disorders in men with a malignancy
  • Autor: Wiechno, Pawel ; Poniatowska, Grazyna ; Michalski, Wojciech ; Kucharz, Jakub ; Sadowska, Malgorzata ; Jonska-Gmyrek, Joanna ; Nietupski, Karol ; Rzymowska, Joanna ; Demkow, Tomasz
  • Assuntos: Testosterone ; Hypogonadism ; Testicular cancer ; Prostate cancer ; Metastatic cancer
  • É parte de: Medical Oncology, 2017, Vol.34(7), pp.1-9
  • Descrição: Cancer and its treatment can lead in men to testosterone deficiency, accompanied by somatic and mental symptoms. Germ cell tumours and their treatment may disturb the pituitary–gonadal axis, hence leading to significant clinical abnormalities. In some prostate cancer patients, castration, temporary or permanent, is a desired therapeutic condition. Yet, it is burdened with various side effects of complex intensity and significance. Last but not least, patients in the terminal stage of a malignancy present with low testosterone concentrations as a part of anorexia–cachexia syndrome. Oncological management of such patients disturbs their homeostasis, androgen metabolism included, which results in numerous complications and worsens their quality of life. In the present paper, we analysed the frequency and sequelae of testosterone deficiency in some clinical scenarios, on the basis of original papers, meta-analyses and reviews available in PubMed. Androgen secretion disorders in male cancer patients depend on a cancer type, stage and methods of treatment. Number of testicular cancer survivors is increasing, and as a consequence, more patients cope with late complications, testosterone deficiency included. Hormone therapy in prostate cancer patients significantly prolongs survival, and then numerous men experience long-term adverse effects of androgen deficiency. Those, in turn, particularly the metabolic syndrome, may contribute to increased mortality. Androgen deficiency is a part of cancer anorexia–cachexia syndrome. The role of androgen deficiency in cancer patients is still under debate, and further studies are urgently needed to establish appropriate clinical guidelines.
  • Idioma: Inglês

Buscando em bases de dados remotas. Favor aguardar.